This content is machine translated SGLT-2 inhibitors and GLP-1-RA How they can protect against diabetic sequelae In recent years, numerous new glucose-lowering agents have been developed. SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular and nephroprotective effects in large clinical endpoint studies. The variety of…
